Crossmark

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal

Crossref DOI link: https://doi.org/10.1186/s13071-019-3743-x

Published Online: 2019-10-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harding-Esch, Emma M. https://orcid.org/0000-0002-1432-8109
Holland, Martin J.

Schémann, Jean-François

Sillah, Ansumana

Sarr, Boubacar

Christerson, Linus

Pickering, Harry

Molina-Gonzalez, Sandra

Sarr, Isatou

Andreasen, Aura A.

Jeffries, David

Grundy, Chris

Mabey, David C. W.

Herrmann, Bjorn

Bailey, Robin L.
Funding

Funding for this research was provided by:

Wellcome Trust (078460/Z/05/Z)
License Information

Text and Data Mining valid from 2019-10-22

Version of Record valid from 2019-10-22
More Information

Article History

Received: 23 April 2019

Accepted: 9 October 2019

First Online: 22 October 2019

Ethics approval and consent to participate

: This study was conducted in accordance with the declaration of Helsinki. Ethical approval was obtained from the London School of Hygiene & Tropical Medicine (LSHTM) ethics committee (No. 2067), the Gambia Government / Medical Research Council Joint Ethics Committee (SCC 979), and the Comité d’éthique du CNRS, Dakar, Senegal. Written (thumbprint or signature) informed consent was obtained from the guardians of all children.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below